1-3 of 3
Sara R Metzler, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naive Follicular Lymphoma (FOL-BRITe): Final Report of Response Rates and Progression Free Survival

Cristiana A Costa, DO, Bassem I Zaki, MD, Stephanie P Yen, MD, Eric S Winer, MD, Helen Ryan, MD, Darcie Findley, Sara R Metzler, RN, Lynn Shaw, RN, Annie Tsui, RN, Todd A MacKenzie, PhD, Anne W Beaven, MD, Frederick Lansigan, MD
Journal: Blood
Blood (2016) 128 (22): 1793.
https://doi.org/10.1182/blood.V128.22.1793.1793
Published: 2016
Journal Articles

Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naïve Follicular Lymphoma: Results of Fol-Brite

Frederick Lansigan, MD, Bassem I Zaki, MD, Stephanie P Yen, MD, Eric S Winer, MD, Helen Ryan, MD, Darcie L Findley, Sara R Metzler, RN, Lynn Shaw, RN, Annie Tsui, RN, Todd MacKenzie, PhD, Anne W Beaven, MD
Journal: Blood
Blood (2014) 124 (21): 1733.
https://doi.org/10.1182/blood.V124.21.1733.1733
Published: 2014
Journal Articles

Short Course of Bendamustine and Rituximab Followed by 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naïve Follicular Lymphoma: Early Results of “Fol-Brite”

Frederick Lansigan, MD, Eric Winer, MD, Sara R Metzler, RN, Lynn Shaw, RN, Peggy Alton, RN, Kate Foster, MPH, Todd MacKenzie, PhD, Anne W Beaven, MD
Journal: Blood
Blood (2012) 120 (21): 3657.
https://doi.org/10.1182/blood.V120.21.3657.3657
Published: 2012